We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Atomwise

News List

Atomwise leverages AI to explore broad-spectrum Covid-19 drugs pharmaceutical-technology
May 26, 2020
Atomwise has forged fifteen research collaborations with universities globally to develop broad-spectrum treatments for Covid-19, as well as other coronaviruses.
BioMotiv and Atomwise sign AI partnership to transform therapeutic development pharmaceutical-business-review
January 17, 2020
BioMotiv, a mission-driven biopharma company, and Atomwise, the leader in using artificial intelligence (AI) for small molecule discovery, announced a strategic collaboration to co-develop therapies.
Lilly and Atomwise partner to use AI for drug discovery pharmaceutical-technology
June 05, 2019
Eli Lilly has formed a multi-target alliance with start-up Atomwise to support preclinical drug discovery efforts.